W. Va. Code R. § 64-52-4 - Circumstances Under Which PertussisVaccine Should Not Be Administered
4.1. Pertussis
vaccine should not be administered to an individual who is less than six weeks
of age or who is seven or more years old, except that in epidemic situations,
immunization may be started as early as two weeks of age, and the first three
doses can be given as frequently as four weeks apart.
4.2. If pertussis vaccine is to be
administered to an individual who is less than six weeks of age and the seventh
birthday, general use guidelines (a recommended immunization schedule based on
data collected by the Advisory Committee on Immunization Practices of the
United States Public Health Service and the Committee on Infectious Diseases of
the American Academy of Pediatrics) provided by the department to local and
county health departments should be consulted.
4.3. Pertussis vaccine should not be
administered to an individual who has an evolving neurologic
disorder.
4.4. When an infant or
child returns for a second or later dose of pertussis vaccine, the parent
should be questioned about any adverse events occurring after the previous
dose.
4.5. Pertussis Vaccine
Contradictions -- Major adverse reactions following pertussis immunization that
constitute absolute contraindications to further administration of pertussis
vaccine are as follows:
(a) collapse or shock
occurring within forty-eight hours;
(b) crying persisting for three or more hours
or an unusual high-pitched cry occurring within forty-eight hours;
(c) temperature of 104.9 degrees fahrenheit
or greater occurring within forty-eight hours;
(d) a convulsion or seizure with or without
accompanying fever occurring up to three days after receipt of pertussis
vaccine;
(e) severe alteration of
consciousness within seven days;
(f) generalized and/or focal neurologic signs
within seven days;
(g) systemic
(severe) allergic reactions within seven days;
(h) excessive somnolence within seven
days;
(i) an evolving neurologic
disorder within seven days; or
(j)
an episode of limpness and paleness within seven days.
If additional circumstances under which pertussis vaccine should not be administered become known by the scientific community, the department will review the above list to determine whether amendment is warranted. Nothing in this section relieves a health care provider from responsibility for reporting all adverse reactions as required under Section 8.1 (c).
4.6.
Pertussis vaccine should not be administered if the individual has had
confirmed Bordetella pertussis infection.
4.7. Pertussis vaccine should not be
administered if the individual is hypersensitive to the vaccine
components.
4.8. The administration
of pertussis vaccine to an individual is not required if, in the written,
signed opinion of the health care provider, the risk to the potential recipient
outweighs the benefits both to the potential recipient and to the
public.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.